SDSalim Demirci

Salim Demirci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Salim Demirci has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Splenic Enlargement During Neoadjuvant Chemotherapy for Gastric Cancer: Treatment-Related Phenomenon or Prognostic Biomarker?

    by Ezgi Altınsoy, Veysel Cem Özcan, Abdurrahman Başpınar, Başak Gülpınar, Selim Tamam, Serdar Çulcu, Salim Demirci

    Introduction: Spleen volume (SV) may increase during systemic chemotherapy, potentially reflecting treatment-related hepatic, hematological, and immune alterations. However, the clinical significance of SV changes during neoadjuvant chemotherapy (NAC) for gastric cancer remains unclear. This study evaluated SV changes during NAC and their associations with radiological response and overall survival (OS). Methods: This retrospective cohort study included 111 patients with gastric adenocarcinoma who received NAC followed by curative-intent gastrectomy. SV was measured on computed tomography before and after NAC using semiautomated volumetric segmentation. Relative SV change (ΔSV%) was calculated. Radiological response was assessed according to RECIST 1.1. Associations of ΔSV% with objective response and OS were evaluated using logistic and Cox regression analyses, respectively. Results: Mean SV increased significantly from 250.59 ± 98.11 to 335.40 ± 126.81 cm3 (p < 0.001), with a mean ΔSV% of 34.53 ± 15.72%. SV increased in 108 patients (97.3%). Objective response was observed in 56 patients (50.5%). ΔSV% did not differ between responders and nonresponders (34.05 ± 15.66% vs. 35.03 ± 15.90%; p = 0.730) and was not associated with objective response after multivariable adjustment (OR per 10% increase, 0.932; 95% CI, 0.715–1.207; p = 0.578). ΔSV% was also not associated with OS (adjusted HR, 1.031; 95% CI, 0.859–1.236; p = 0.745). Conclusions: SV increased markedly in nearly all patients during NAC for gastric cancer. However, the magnitude of this increase was not associated with radiological response or OS, suggesting that splenic enlargement during NAC may represent a treatment-associated phenomenon rather than a marker of antitumor efficacy or prognosis.

  • Long-term oncological outcomes of extralevator versus standard abdominoperineal resection with 20 years’ experience

    by Ulvi Mecidli, Burak Kutlu, Atilla Halil Elhan, Akın Fırat Kocaay, Cihangir Akyol, Atıl Çakmak, Ali Ekrem Ünal, Salim Demirci, İsKender Alaçayır, Mehmet Ayhan Kuzu

  • Open Access

    Stoma bölgesinin işaretlenmesinin stoma kalitesine etkisi var mıdır?

    by Salim İlksen Başçeken, Şeref Dokcu, Mehmet Ali Caparlar, Fatih Aslan, Salim Demirci

    ÖZ Amaç Stoma yapımı kolorektal cerrahi prosedürlerin vazgeçilmez parçasıdır. Cerrahlar stoma ile yapmış oldukları anastomozun morbiditesinden kurtulmayı ummaktadırlar. Stomalar hem oluşturulma hem de kapanmaları esnasında yüksek morbidite kaynağıdırlar. Sorunsuz stomalar hem sağlık maliyetlerini azaltır, hemde hasta yaşam kalitesini desteklerler. Bu çalışmamızda stoma ve yara bakımı hemşiresi tarafından ameliyat öncesi yapılan işaretlemenin stoma kalitesi ile ilişkisini ortaya koymayı amaçladık. Gereç ve Yöntemler Çalışmaya onkoloji kliniğimizde malign tanılarla opere edilip stoma oluşturma ihtiyacı duyulan 150 hasta dahil edildi. Hastaların WOC hemşiresince tutulan tıbbi kayıtları ve veri tabanı geriye dönük olarak incelendi. Demografik ve klinikopatolojik veriler kaydedilip, gruplandırıldı. Hem acil hem de elektif prosedürler geçiren hastalar çalışmaya dahil edildi. İstatistiksel analizler yüzde 95 güven aralığında yapıldı. P değerinin 0,05'ten küçük olması istatistiksel olarak anlamlı kabul edildi. Bulgular Stoma bölgesinin işaretlenme durumu ve VKİ ile, komplikasyonlar arasında anlamlı bir ilişki izlendi, (p=0.03, p=0,01). İleostomili hastalar kolostomili hastalardan anlamlı derecede fazla peristomal cilt komplikasyonlarıyla ( PSC) ilişkiliydi, (p=0.02).Yine yapılan fark analizinde de stoma işaretleme durumu ile stoma çapları arasında anlamlı bir farklılaşma izlendi, büyük stoma çapları WOC hemşiresince konsulte edilmeyen hastalarla ilişkiliydi, (p=0,001). Sonuç Bulgular WOC hemşiresi tarafından operasyon öncesi yapılacak olan konsültasyonun stoma kalitesini etkileyen komplikasyonlar ve stoma çapı ile ilişkili olduğunu göstermiştir.


  • Liver Dysfunction After Use of Nathanson Retractor During Laparoscopic Gastrectomy for Gastric Cancer

    by Serdar Culcu, Selim Tamam, Cem Azili, Siyar Ersoz, Baris Morkavuk, Ali Ekrem Unal, Salim Demirci

    Background: Cardiopulmonary complications and liver dysfunction are also specific complications and problems associated with laparoscopic surgery. The main causes of postoperative liver dysfunction, which may often occur after laparoscopic surgery, include carbon dioxide pneumoperitoneum and ligation of the aberrant left hepatic artery. Hepatic steatosis may develop as a natural consequence of neoadjuvant therapy, although rarely, owing to chemotherapy. Nathanson retractor may cause a prolonged elevation in liver enzymes of these patients compared with those who do not receive neoadjuvant therapy. Materials and Methods: The data of 151 patients who underwent laparoscopic radical gastrectomy between January 2017 and January 2022 for histologically proven primary gastric cancer in our clinic were retrospectively reviewed. Results: The mean length of hospital stay was 6.21 days. The mean time normalization of the aspartate aminotransferase (AST) value was 2.45 ± 1.83 (range, 0–12) days postoperatively. The analysis of the correlation between the preoperative and postoperative 1-day values of alanine aminotransferase (ALT) and AST revealed a significant difference between the preoperative and postoperative 1-day median values of both parameters ( P < .001). Each one unit increase in ALT led to an increase of 0.338 days in the length of intensive care stay and an increase of 0.345 days in the overall length of hospital stay. As the time to normalization of the AST value increased, the length of both intensive care stay and hospital stay increased. Each one unit increase in AST resulted in an increase of 0.316 days in the length of intensive care stay and an increase of 0.376 days in the overall length of hospital stay. Conclusion: Alternative retraction methods can be used safely in laparoscopic surgery for gastric cancer patients receiving neoadjuvant therapy. We are of the opinion that the Nathanson retractor should be used only during dissection of the relevant regions to shorten the intraoperative intermittent release or the time of use.


  • Open Access

    Can CT Pelvimetry Be Used to Predict Circumferential Resection Margin Positivity in Laparoscopic Resection of Middle and Lower Rectum Cancer?

    by Afig Gojayev, Cemil Yuksel, Serkan Akbulut, Ogün Erşen, Batuhan Bakırarar, Başak Gülpınar, Ayşegül Gürsoy Çoruh, Ali Ekrem Unal, Salim Demirci

    Previous studies have shown that pelvimetry can be valuable in predicting surgical difficulties in rectal cancer operations. However, its usability in predicting circumferential resection margin (CRM) involvement remains debatable. This study investigated the factors affecting CRM status and the importance of computed tomography (CT) pelvimetry in predicting CRM involvement in laparoscopic resection of middle and lower rectal cancer. In this study, we retrospectively investigated the data of 111 patients who underwent a laparoscopic operation for middle and lower rectum cancer at Ankara University Faculty of Medicine, Department of Surgical Oncology between January 2014 and January 2020. The predictive value of CT pelvimetry and other variables on the CRM status was analyzed. The following four pelvic parameters differed significantly between the genders: transverse diameter of the pelvic inlet (p = 0.024), anteroposterior diameter of the pelvic outlet (p = 0.003), transverse diameter of the pelvic outlet (p < 0.001), and pelvic depth (p < 0.001). The effect of pelvic anatomic parameters on CRM involvement was not found to be significant. It was found that tumor height from the anal verge (p = 0.004), tumor size (p < 0.001), and gender (p = 0.033) were significant risk factors for CRM involvement. Survival was poor in patients with male gender (p = 0.032), perineural invasion (p < 0.001), and grade 3 tumor. In this study, no benefit was found in predicting CRM positivity from CT pelvimetry in the laparoscopic resection of middle and lower rectal cancer. Besides, tumor height from the anal verge, tumor size, and gender were important factors for CRM positivity. Although our study sheds light on this issue, prospective randomized studies with larger sample sizes are needed.


  • Open Access

    Clinicopathological characteristics and management of patients with early readmission to our surgical oncology clinic

    by Mehmet Ali Çaparlar, Şeref Dokcu, Salim Demi̇rci̇

    Objectives: This study aimed to discuss the frequency of early readmission to the hospital after discharge in our oncology clinic, clinicopathological features, and management of these patients in light of current literature. Methods: The medical records of 237 early readmitted patients within 30 days of discharge in our clinic were retrospectively reviewed. The patients were categorized according to their first diagnosis, Eastern Cooperative Oncology Group (ECOG) performance status, demographic, clinicopathological characteristics, readmission reasons, first treatment type, postoperative complications, the time of application after discharge and the type of treatment after admission.Results: The mean age of the patients was 58.45 years, 57.4% were female, and the mean readmission time after discharge was 11.54 days. The most common primary diagnosis was gastric cancer (35.9%), and the most common emergency pathology requiring hospitalization was ileus-subileus (45.1%). After readmission, 42.6% of the patients received medical treatment. 60% of the readmitted patients had postoperative complications before discharge. Patients who had postoperative complications during the first hospitalization were more likely to have major or minor interventions after readmission (p < 0.01). Admission with a diagnosis of bowel obstruction was associated with the probability of major intervention (p < 0.01). Patients with an ECOG performance score of ≥2 was more frequently administered medical treatment (p = 0.001). Patients admitted with the diagnosis of anastomotic leak/abscess had a higher probability of having postoperative complications (p = 0.001). Conclusions: Readmissions are a concern for all healthcare providers, including comprehensive cancer centers. Recent health policies strive to reduce preventable admissions. Hence, we believe focusing on postoperative complications, and palliative care services is necessary.

  • Open Access

    Loop ileostomy or loop transverse colostomy for resectable rectal cancers

    by Mehmet Ali Çaparlar, Şeref Dokçu, Salim Demi̇rci̇

    Objectives: This retrospective study aimed to compare loop ileostomy (LI) with loop transverse colostomy (LTC) as covering stoma regarding the perioperative outcomes in patients who underwent low anterior resection for rectal cancer between 2015 and 2020. Methods: Data were collected from patient files and the hospital's electronic database. The primary outcome measure was complications related to stoma formation, stoma reversal, and overall complications. Secondary outcome measures were hospital discharge time and readmission rate after discharge. Results: A total of 90 patients (38 female, 52 male; 56.6 ± 6.8 years) were included in the study. There were two groups considering the technique for covering stoma: Group LI (n = 50) and Group LTC (n = 40). Demographic and perioperative characteristics were similar. Primary outcome measure: Postoperative course was complicated in 49 (54.4%) patients. The complication rate was higher in the group LI than the group LTC (62% vs 45%; p = 0.03). Among them, 29 (59.2%) complications were related to the stoma formation related, and 14 (28.6 %) complications were related to the stoma reversal related, and 6 (12.2%) were overall complications. The rate of complications related to the stoma formation was higher in the group LI compared to the group LTC (20 [40%] vs. 9 [22.5%]; p = 0.01). The most common complication was periostomal skin irritation (48.3%) followed by dehydration (13.8%), stoma retraction (10.3%) patients, parastomal hernia (10.3%), bleeding (6.9%), anastomotic leak (3.4%), incisional hernia (3.4%), and high-output stoma (3.4%). Complications including incisional hernia, high output stoma, and anastomotic leakage (Grade C; requiring laparotomy) were observed only in the group LI. The morbidity rate in 30 days after the surgery was higher in the group LI compared to the group LTC (16 [32%] vs. 8 [20%]; p = 0.02). A total of 14 stoma reversal complications included incisional hernia in 7 (14.3%) patients, wound infection in 5 (10.2%) patients, and rectal bleeding in 2 (4.1%) patients. The rate of complications was not different between groups (16% vs. 15%; p = 0.41). Overall complications were similar between study groups (3 complications in each group; p = 0.73). Secondary outcome measure: The group LTC patients were discharged earlier compared to the group LI (7.1 ± 2.0 days vs. 9.4 ± 2.5 days; p = 0.03). The readmission rate after hospital discharge was higher in the LI group than the group LTC (18% vs. 12.5%; p = 0.02). Conclusions: It was concluded that LTC was superior compared to LI concerning complications after low anterior resection for rectum cancer.


  • The effect and clinical significance of using nathanson liver retractor on liver function tests in laparoscopic gastric cancer surgery

    by Afig Gojayev, Cemil Yüksel, Ümit Mercan, Mehmet Ali Çaparlar, Ozhan Cetindag, Serkan Akbulut, Ali Ekrem Ünal, Sancar Bayar, Salim Demirci

    Aim: There are very few studies in the literature investigating the changes caused by the Nathanson retractors in liver function tests (LFT) after LG and its clinical significance. The present study investigated the changes made by the Nathanson retractor used during LG on LFT and its clinical significance. Material and Method: The data of 236 patients, who underwent radical gastrectomy for primary gastric cancer at Surgical Oncology Unit in the period between January 2015 and January 2020 were retrospective studied. The patients were divided into two groups: laparoscopic gastrectomy (LG; 136 cases) and open gastrectomy (OG; 106 cases). Patients who have undergone cholecystectomy, with primary or secondary liver tumors, with chronic hepatic disease, who have preoperative high ALT, AST and bilirubin values were excluded from the study. LFT were measured preoperatively and postoperative day 1 (LFT1), LFT3, LFT5 and LFT7. LFT: ALT, AST and Total bilirubin (BIL). Results: ALT1, ALT3, ALT5, ALT7 ALT values and AST1, AST3, AST5 AST values of the patients in the LG group were found to be significantly higher (P 0.05). In order to evaluate how the increase in LFT due to the use of the Nathanson retractors reflected on the patients' clinic, we divided the patients who underwent LG into two groups based on ALT increase in ALT1: Normal and Elevated. The in-hospital mortality rates (P = 0.080) and oral nutrition time (P = 0.913) of the groups were similar. No liver infarction developed in any of the groups. The duration of stay in the ICU was significantly longer in individuals with elevated LFT (P = 0.019). Conclusion: Although the use of the Nathanson retractor during LG causes an increase in liver function tests, this does not cause major clinical problems in patients. Key Words: Gastrectomy; gastric cancer; laparoscopy; liver enzymes; liver dysfunciton


  • Our Short- and Long-Term Results of Laparoscopic Gastrectomy in Locally Advanced Gastric Cancer

    by Serdar Çulcu, Cemil Yüksel, Salim Demirci, Ali Ekrem Ünal, Sancar Bayar, Afig Gojayev

  • The Impact of the COVID-19 Pandemic on Gastric Cancer Surgery: A Single-Center Study.

    by Afig Gojayev, Cemil Yuksel, Ogun Ersen, Haydar Celasin, Ali Ekrem Unal, Salim Demirci

    Introduction: Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. The impact on gastric cancer (GC) surgery is unknown. Various reports have shown data indicating that cancer patients with COVID-19 have high morbidity and mortality rates. The choice of surgical procedures and perioperative management of the patients with malignancy has become even more impor¬tant in the COVID-19 pandemic. In this study, we aimed to evaluate the effects of the COVID-19 pandemic on the preopartive, intraoperative, and postoperative findings of patients operated for gastric cancer in our clinic. Materials and Methods: We defined the ‘COVID-19’ period as occurring between 12-03-2020 and 31-08-2020. All the enrolled patients were divided into two groups, pre-COVID-19 group (Pre-CG; 64 cases) and COVID-19 group (CG; 39 cases). A total of 103 patients with gastric cancer were included in this study. Patient characteristics, preoperative, intraoperative, and postoperative clinicopathological findings were compared between groups. Results: The waiting times before admission increased in CG (Pre-CG [6.73±2.85] vs CG [20.61±5.16] ; p<0.001). After admission, the waiting time before surgery was longer in CG (Pre-CG [5.06±3.06] vs CG [6.89±3.32] ; p=0.006). No significant difference was detected between the groups in terms of operation time, surgical procedure, combine organ resection, intraoperative blood transfusion requirment (p values, respectively; p=0.108; p=0.951; p=0.204; p=0.597). Postoperative complications were oesophagojejunostomy leak (3/1) , atelectasis (2/2), duodenal leak (2/2), ileus (3/0), pleural effusion (2/2), and others (1/1), and there was no statistically significant difference between the two groups (p = 0.333). There was no significant difference between the two groups in terms of hospital stay (p = 0.086) and ICU stay (p = 0.989). Conclusion: In this study, it was seen that the COVID-19 pandemic did not affect morbidity and mortality in gastric cancer surgery, but it prolonged admission waiting and operation waiting times. Since there is very little data in the literature regarding the effect of COVID-19 on gastric cancer surgery, our study will guide future studies on this subject. Keywords: COVID-19, Impact, Gastric Cancer, Pandemics, Surgery